These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 20418469)
41. Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology. Hosseini E; Pedram B; Bahrami AM; Touni SR; Malayeri HZ; Mokarizadeh A; Pourzaer M; Pourzaer M; Zehtabian S; Mohajer S; Ahmadi S Tumour Biol; 2015 Feb; 36(2):929-37. PubMed ID: 25315185 [TBL] [Abstract][Full Text] [Related]
42. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs. Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531 [TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical detection of CD34, E-cadherin, claudin-1, glucose transporter 1, laminin, and protein gene product 9.5 in 28 canine and 8 feline meningiomas. Ramos-Vara JA; Miller MA; Gilbreath E; Patterson JS Vet Pathol; 2010 Jul; 47(4):725-37. PubMed ID: 20403881 [TBL] [Abstract][Full Text] [Related]
45. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103 [TBL] [Abstract][Full Text] [Related]
46. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization. Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946 [TBL] [Abstract][Full Text] [Related]
47. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Coupland SE; Krause L; Delecluse HJ; Anagnostopoulos I; Foss HD; Hummel M; Bornfeld N; Lee WR; Stein H Ophthalmology; 1998 Aug; 105(8):1430-41. PubMed ID: 9709754 [TBL] [Abstract][Full Text] [Related]
48. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors. Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564 [TBL] [Abstract][Full Text] [Related]
49. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Reith JD; Goldblum JR; Lyles RH; Weiss SW Mod Pathol; 2000 May; 13(5):577-85. PubMed ID: 10824931 [TBL] [Abstract][Full Text] [Related]
50. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours. Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679 [TBL] [Abstract][Full Text] [Related]
51. Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat. Lamm CG; Stern AW; Smith AJ; Cooper EJ; Ullom SW; Campbell GA J Vet Diagn Invest; 2009 Sep; 21(5):710-5. PubMed ID: 19737771 [TBL] [Abstract][Full Text] [Related]
52. The morphology and behavior of feline cutaneous mastocytomas. Wilcock BP; Yager JA; Zink MC Vet Pathol; 1986 May; 23(3):320-4. PubMed ID: 3088812 [TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic description of a cutaneous melanocytic tumor in a 1-year-old cat. Bae MK; Cha JW; Lim HY; Kim CW; Han SH; Sur JH; Yhee JY Vet Clin Pathol; 2024 Sep; 53(3):369-373. PubMed ID: 39313773 [TBL] [Abstract][Full Text] [Related]
54. Ki67 as a biologic marker of basal cell carcinoma: a retrospective study. Kramer E; Herman O; Frand J; Leibou L; Schreiber L; Vaknine H Isr Med Assoc J; 2014 Apr; 16(4):229-32. PubMed ID: 24834759 [TBL] [Abstract][Full Text] [Related]
55. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells. Meyer A; Gruber AD; Klopfleisch R Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323 [TBL] [Abstract][Full Text] [Related]
56. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Isotani M; Tamura K; Yagihara H; Hikosaka M; Ono K; Washizu T; Bonkobara M Vet Immunol Immunopathol; 2006 Nov; 114(1-2):168-72. PubMed ID: 16908071 [TBL] [Abstract][Full Text] [Related]
57. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
58. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours. Sabattini S; Barzon G; Giantin M; Lopparelli RM; Dacasto M; Prata D; Bettini G Vet Comp Oncol; 2017 Sep; 15(3):1051-1061. PubMed ID: 27278268 [TBL] [Abstract][Full Text] [Related]
59. Histologic characteristics and KIT staining patterns of equine cutaneous mast cell tumors. Clarke L; Simon A; Ehrhart EJ; Mulick J; Charles B; Powers B; Duncan C Vet Pathol; 2014 May; 51(3):560-2. PubMed ID: 23794148 [TBL] [Abstract][Full Text] [Related]
60. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors. Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]